AESICA Trademark

Trademark Overview

On Tuesday, February 27, 2018, a trademark application was filed for AESICA with the United States Patent and Trademark Office. The USPTO has given the AESICA trademark a serial number of 87811886. The federal status of this trademark filing is REGISTERED as of Tuesday, January 15, 2019. This trademark is owned by Aesica Pharmaceuticals Limited. The AESICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation, arthritis, dementia, cancer, pain or mood disorders, such as, anxiety, depression and dysthymia
aesica

General Information

Serial Number87811886
Word MarkAESICA
Filing DateTuesday, February 27, 2018
Status700 - REGISTERED
Status DateTuesday, January 15, 2019
Registration Number5653181
Registration DateTuesday, January 15, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammation, arthritis, dementia, cancer, pain or mood disorders, such as, anxiety, depression and dysthymia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCONSORT MEDICAL LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressKING'S LYNN, NORFOLK PE30 2JJ
GB
Party NameAesica Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressNorthumberland NE233JL
GB
Party NameAesica Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressHertfordshire HP24TZ
Party NameAesica Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressHertfordshire HP24TZ

Trademark Events

Event DateEvent Description
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 19, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, February 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 13, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 13, 2018NON-FINAL ACTION E-MAILED
Thursday, September 13, 2018NON-FINAL ACTION WRITTEN
Thursday, September 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 5, 2018ASSIGNED TO LIE
Tuesday, August 21, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 12, 2018NON-FINAL ACTION E-MAILED
Tuesday, June 12, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 12, 2018ASSIGNED TO EXAMINER
Monday, March 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 2, 2018NEW APPLICATION ENTERED

Related Keywords

aesica disorders mood such anxiety dysthymia depression pain cancer treatment preparations